Full-Time

Senior Delivery Lead

Confirmed live in the last 24 hours

BenchSci

BenchSci

201-500 employees

AI-driven platform for preclinical research

AI & Machine Learning
Biotechnology

Senior

No H1B Sponsorship

Remote in Canada

Category
Project Management
Strategy Development
Business & Strategy
Requirements
  • 3+ years of experience in project or program management that spans multiple domains of expertise.
  • 3+ years experience in customer success for B2B enterprises and global organizations.
  • Educational background or working experience in a life sciences or technology discipline.
  • Experience crafting and delivering presentations in front of audiences of all sizes in a professional setting.
  • Experience navigating complex subject matter and working with multiple stakeholders at different levels.
  • Comfortable dealing with ambiguity and finding a path forward.
  • A knack for interpreting complex data and defining strategies and tactics to improve trends.
  • A passion for driving progress in the life sciences.
  • A thirst to be part of a team that is focused on transformation and world-class delivery.
  • Willingness and ability to travel internationally up to 20% of the time.
Responsibilities
  • Support high-profile complex programs and help in the creation of the best path to empowering scientists with our generative AI platform for drug discovery acceleration.
  • Develop strong relationships with customers to ensure successful deployment and ongoing adoption of our technology.
  • Facilitate touchpoints with key points of contact, and prepare content and/or present at executive review meetings. Partner with the account teams to develop and execute account-specific adoption activities that drive awareness, usage, advocacy, and value.
  • Participate in user calls, ensuring ongoing efficacy of engagement strategies and improvements to adoption metrics.
  • Forecast support needs and monitor and control the health and risks of critical deliverables.
  • Use metrics and reporting to help grow scientist engagement and utilization of BenchSci technology.
  • Champion continuous improvement, identifying opportunities for more consistent and efficient execution.

BenchSci operates in the biotechnology sector, focusing on preclinical research and development. Its main product, ASCEND, uses artificial intelligence and machine learning to extract and organize data from various sources, helping scientists generate hypotheses, develop experimental approaches, and identify risks. What makes BenchSci different is its user-friendly platform that can be easily deployed across research organizations, making it accessible for scientists at any stage of their projects. The company's goal is to enhance the efficiency of research efforts and contribute to more effective scientific discoveries.

Company Stage

Series D

Total Funding

$156.6M

Headquarters

Toronto, Canada

Founded

2015

Growth & Insights
Headcount

6 month growth

-1%

1 year growth

-13%

2 year growth

1%
Simplify Jobs

Simplify's Take

What believers are saying

  • BenchSci's recent $95 million CAD Series D funding and $40 million investment from Generation Investment Management highlight strong financial backing and growth potential.
  • Recognition as a 2023 Best Workplace for Inclusion and the launch of employee resource groups reflect a positive and inclusive company culture.
  • The launch of ASCEND and new AI tools to map disease biology demonstrate BenchSci's commitment to innovation and improving R&D efficiency.

What critics are saying

  • The recent elimination of 17% of its workforce could indicate financial instability or strategic pivots that may affect employee morale.
  • The competitive landscape in AI-driven biotech solutions is intense, requiring continuous innovation to maintain a leading position.

What makes BenchSci unique

  • BenchSci leverages proprietary AI and machine learning to create a comprehensive map of disease biology, setting it apart from competitors who may not offer such advanced data integration.
  • The ASCEND platform's ability to assist in hypothesis generation, experimental approaches, and risk identification provides a unique, end-to-end solution for preclinical R&D.
  • BenchSci's focus on preclinical research and development, combined with its intuitive enterprise deployment, makes it a specialized tool for scientists and research organizations.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote-first culture

Equity options

15 days vacation + additional day every year

Unlimited flex time

Comprehensive health & dental benefits

Psychotherapist services

Annual Learning & Development budget

Home office set-up budget

Wellness, lifestyle & productivity spending account